With type 2 diabetes, ‘we’re failing right now,’ FDA chief says
FDA Commissioner Robert Califf highlighted the concerning trend of deteriorating health outcomes in the U.S., particularly in relation to chronic diseases like type 2 diabetes. While advancements in technology and…
Six tips for staying safe
Extreme heat poses risks for people spending time outdoors, such as runners, workers, and children. It is essential to adjust activities to avoid the hottest part of the day, hydrate…
Nutritious diet may protect against type 2 diabetes, regardless of genetics
A study from the University of Eastern Finland shows that adhering to a healthy diet can lead to better blood glucose levels and lower the risk of prediabetes and type…
Inhaled Insulin Plus Degludec an Option for Type 1 Diabetes
Afrezza, an inhaled insulin approved by the US FDA in 2014, when combined with long-acting basal analog insulin, has shown to be a non-inferior treatment option for those with type…
Modernizing – and Securing – Hospital Technology Infrastructure
The healthcare industry is experiencing a digital transformation driven by the need for improved patient outcomes, operational efficiency, and evolving technological trends. However, many hospitals face budget constraints that hinder…
Fenofibrate reduces progression of diabetic eye disease
A study presented at the American Diabetes Association Scientific Sessions found that oral fenofibrate, a lipid-lowering drug, was associated with a 27% reduction in progression of diabetic eye disease over…
Medicare coverage of Wegovy, cancer tests: new bill considered
The House panel is considering voting on scaled-back versions of health care bills to expand Medicare coverage for cancer screening tests and weight loss drugs. The full coverage of these…
Chiropractors have been banned again from manipulating babies’ spines. Here’s what the evidence actually says
Chiropractors in Australia are once again banned from performing spinal manipulation on children under the age of two due to health concerns. The controversy arose from a video showing a…
Sobi’s ALTUVOCT receives EU marketing authorization
Sobi® has received Marketing Authorization from the European Commission for ALTUVOCT™ (efanesoctocog alfa) for the treatment of hemophilia A. ALTUVOCT is a sustained factor VIII replacement therapy for all ages…
Delaying Statin Therapy in Diabetes Increases CV Risk
Delaying treatment with recommended statin therapy for patients with type 1 and 2 diabetes leads to significantly higher rates of cardiovascular events over a 10-year follow-up period. Those who accepted…